Grufity logoGrufity logo

VTRS

11.17USD-0.07(-0.62%)Market Closed

Viatris Inc

Market Summary

USD11.17-0.07Market Closed
-0.62%

VTRS Alerts

VTRS Stock Price

RSI Chart

Valuation

Market Cap

12.2B

Price/Earnings

16.05

Price/Sales

0.71

Price/Cashflow

3.44

MarketCap/EBT

13.38

Price/Sales

Profitability

EBT Margin

5.31%

Return on Equity

3.84%

Return on Assets

1.49%

Fundamentals

Revenue

Revenue (TTM)

16.7B

Revenue Y/Y

-10.1%

Revenue Q/Q

-0.94%

Earnings

Earnings (TTM)

803.6M

Earnings Y/Y

13.74%

Earnings Q/Q

12.87%

Price Action

52 Week Range

14.97
(Low)(High)

Last 7 days

0.3%

Last 30 days

12.1%

Last 90 days

19.5%

Trailing 12 Months

-4.6%

Financial Health

Current Ratio

1.46

Debt/Equity

0.56

Debt/Cashflow

0.26

Investor Care

Dividend Yield

4.77%

Dividend/Share (TTM)

0.48

Shares Dilution (1Y)

0.27%

Diluted EPS (TTM)

0.66

Peers (Alternatives to Viatris)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.4T
394.3B
2.09% -9.22%
23.61
5.98
7.79% 5.41%
1.8T
203.1B
16.19% -21.88%
25.2
8.66
15.22% 2.81%
1.3T
282.1B
15.80% -29.87%
18.7
4.44
17.94% -5.14%
960.3B
502.2B
2.18% -45.23%
84.81
1.91
9.66% -56.89%
MID-CAP
2.5B
8.6B
2.72% -42.67%
-5.69
0.31
76.30% -20.89%
SMALL-CAP
1.9B
628.4M
27.93% -51.99%
-4.08
3.1
64.35% -18.14%
1.9B
1.6B
8.77% 21.76%
12.45
1.23
81.91% 208.48%
1.5B
-
32.82% -58.59%
-0.54
1.95
-4.11% -144.36%
1.4B
40.0M
-13.64% -71.15%
-1.84
34.64
34.91% -55.12%
1.0B
247.8M
11.54% -12.57%
-17.78
4.46
23.41% -194.70%
1.0B
412.4M
14.61% -28.22%
-153.63
2.47
51.09% -102.33%
988.1M
439.7M
-3.05% -78.77%
-2.97
2.13
-5.64% -199.38%
861.5M
1.2B
6.13% -46.00%
2.31
0.73
7.66% 583.60%
551.2M
2.2M
-7.04% -70.05%
-1.55
343.43
-72.60% -50.32%

Financials for Viatris

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-2.7%16,72817,18717,64817,88617,168
Gross Profit2.6%6,7696,5956,2195,5764,736
Operating Expenses-0.6%5,0315,0595,2805,6107,993
  S&GA Expenses-0.9%3,9974,0344,2584,5294,808
  R&D Expenses3.1%747724709751639
Earnings Before Taxes24.9%1,140913304-664.40-959.70
Net Income5.6%804761168-1,269.10-1,505.20
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-4.8%48,66351,12553,46754,84356,070
  Current Assets-6.2%10,48811,17711,74410,90311,308
    Cash Equivalents-2.7%647665752701757
  Inventory-6.4%3,3803,6133,7973,9784,082
  Net PPE-1.5%3,0393,0843,1503,1893,114
  Goodwill-4.5%10,05510,52310,97912,11412,170
Liabilities-5.9%29,48031,32033,01934,35034,929
  Current Liabilities-15.1%6,5217,6819,6439,88410,104
.    Short Term Borrowings-50.9%5001,0206551,4931,707
    LT Debt, Current-0.6%7647682,6061,8781,908
    LT Debt, Non Current-2.5%18,72519,20618,76319,71719,854
Shareholder's Equity-3.1%19,18219,80520,44820,49321,141
  Retained Earnings5.0%4,3134,1073,9423,6894,087
  Additional Paid-In Capital0.2%18,61718,58618,55518,53618,514
Shares Outstanding0.1%1,2121,2111,209--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-6.1%3,3333,5503,3073,0173,725
  Share Based Compensation3.9%109105107111118
Cashflow From Investing0.7%-483.10-486.30-421.00-117.8011,213
Cashflow From Financing3.9%-2,896.50-3,015.30-2,921.20-3,012.00-2,513.70
  Dividend Payments-532

Risks

What is the probability of a big loss on VTRS?

100%


Probability that Viatris stock will be more than 20% underwater in next one year

71.5%


Probability that Viatris stock will be more than 30% underwater in next one year.

25.8%


Probability that Viatris stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does VTRS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Viatris was unfortunately bought at previous high price.

Returns

Cumulative Returns on VTRS

-8.0%


10-Year Cumulative Returns

-18.8%


7-Year Cumulative Returns

-20.8%


5-Year Cumulative Returns

-13.7%


3-Year Cumulative Returns

What are the long-term rolling returns for VTRS?

FIve years rolling returns for Viatris.

Which funds bought or sold VTRS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Toroso Investments, LLC
ADDED
27.3
20,000
575,000
0.02%
2022-11-23
Gould Capital, LLC
UNCHANGED
-
-
-
-%
2022-11-23
Repertoire Partners LP
SOLD OFF
-100
-345,000
-
-%
2022-11-23
Eagle Bay Advisors LLC
ADDED
36.15
4,532
41,000
0.03%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
941,000
941,000
0.01%
2022-11-22
MFA Wealth Advisors, LLC
-
-
50,000
537,000
0.20%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
81.3
99,000
307,000
0.01%
2022-11-22
CVA Family Office, LLC
-
-
1,000
4,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-4,156,000
17,358,000
0.03%
2022-11-21
FourThought Financial, LLC
-
-
-8,000
17,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying VTRS calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own VTRS

Viatris News

InvestorsObserver

Viatris Inc (VTRS) has risen 0.62% Friday In Premarket Trading.37 hours ago

VTRS Fair Value

Recent SEC filings of Viatris

View All Filings
Date Filed Form Type Document
Nov 29, 2022
8-K
Current Report
Nov 14, 2022
DEFA14A
DEFA14A
Nov 14, 2022
SC TO-C
SC TO-C
Nov 08, 2022
SC TO-C
SC TO-C
Nov 07, 2022
10-Q
Quarterly Report
Nov 07, 2022
8-K
Current Report
Nov 07, 2022
8-K
Current Report
Nov 07, 2022
SC TO-C
SC TO-C
Oct 28, 2022
DEF 14A
DEF 14A
Oct 28, 2022
DEFA14A
DEFA14A

Latest Insider Trading transactions for VTRS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-08-17
van der Meer Mohr Pauline
SOLD
-99,912
10.5839
-9,440
-
2022-05-27
Taddese Menassie
SOLD
-106,406
12.0737
-8,813
See Remarks
2022-03-29
Ni Xiangyang (Sean)
ACQUIRED
-
-
2,954
President, Greater China
2022-03-21
CORNWELL W DON
ACQUIRED
-
-
166
-
2022-03-21
READ IAN C
ACQUIRED
-
-
166
-
2022-03-21
GOETTLER MICHAEL
SOLD (Taxes)
-2,909.2
10.39
-280
Chief Executive Officer
2022-03-21
van der Meer Mohr Pauline
ACQUIRED
-
-
166
-
2022-03-21
Taddese Menassie
ACQUIRED
-
-
80
See Remarks
2022-03-21
HIGGINS MELINA E
ACQUIRED
-
-
166
-
2022-03-21
DIMICK NEIL F
ACQUIRED
-
-
166
-

1–10 of 50

Michael Goettler
37000
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

VTRS Income Statement

2022-09-30
Condensed Consolidated Statements Of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues [Abstract]    
Net sales$ 4,067.4$ 4,520.5$ 12,351.0$ 13,482.3
Total revenues4,078.24,536.612,386.713,544.7
Cost of sales2,329.82,962.57,163.89,515.6
Gross profit1,748.41,574.15,222.94,029.1
Operating expenses:    
Research and development174.9152.1479.8483.9
Selling, general and administrative1,017.31,055.02,913.73,446.3
Litigation settlements and other contingencies, net(3.9)9.413.255.3
Total operating expenses1,188.31,216.53,406.73,985.5
Earnings from operations560.1357.61,816.243.6
Interest expense153.2151.9445.3488.0
Other (income) expense, net(20.6)5.826.616.1
Earnings before income taxes427.5199.91,344.3(460.5)
Income tax provision (benefit)73.2(111.6)276.9544.8
Net earnings (loss)$ 354.3$ 311.5$ 1,067.4$ (1,005.3)
Earnings (loss) per share attributable to Viatris Inc. shareholders    
Basic (in USD per share)$ 0.29$ 0.26$ 0.88$ (0.83)
Diluted (in USD per share)$ 0.29$ 0.26$ 0.88$ (0.83)
Weighted average shares outstanding:    
Basic (in shares)1,212.51,209.31,211.81,208.6
Diluted (in shares)1,218.11,212.61,216.11,208.6
Other Revenues    
Revenues [Abstract]    
Other revenues$ 10.8$ 16.1$ 35.7$ 62.4

VTRS Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 646.7$ 701.2
Accounts receivable, net3,333.94,266.4
Inventories3,380.43,977.7
Prepaid expenses and other current assets1,700.41,957.6
Assets held for sale1,426.40.0
Total current assets10,487.810,902.9
Property, plant and equipment, net3,039.03,188.6
Intangible assets, net23,013.326,134.2
Goodwill10,054.612,113.7
Deferred income tax benefit1,104.01,332.7
Other assets963.91,170.7
Total assets48,662.654,842.8
Current liabilities:  
Accounts payable1,310.51,657.4
Short-term borrowings500.41,493.0
Income taxes payable106.7236.9
Current portion of long-term debt and other long-term obligations763.81,877.5
Liabilities held for sale335.30.0
Other current liabilities3,504.74,619.6
Total current liabilities6,521.49,884.4
Long-term debt18,724.519,717.1
Deferred income tax liability2,489.32,815.0
Other long-term obligations1,745.11,933.6
Total liabilities29,480.334,350.1
Viatris Inc. shareholders’ equity  
Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,212,653,465 and 1,209,507,463, respectively12.112.1
Additional paid-in capital18,616.818,536.1
Retained earnings4,312.53,688.8
Accumulated other comprehensive loss(3,759.1)(1,744.3)
Total equity19,182.320,492.7
Total liabilities and equity$ 48,662.6$ 54,842.8